Treace Medical Concepts (TMCI) Invested Capital (2020 - 2026)

Treace Medical Concepts (TMCI) has reported Invested Capital for 7 consecutive years, with $130.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Invested Capital fell 15.12% year-over-year to $130.1 million; the trailing twelve-month figure through Jun 2026 stood at $130.1 million (down 15.12% YoY), and the FY2025 full-year result was $146.4 million, down 11.91% from the prior year.
• Invested Capital fell to $130.1 million in Q2 2026 per TMCI's latest filing, from $136.6 million in the prior quarter.
• Across five years, Invested Capital topped out at $210.4 million in Q1 2023 and bottomed at $113.2 million in Q4 2022.
• Historically, Invested Capital has averaged $155.8 million across 5 years, with a median of $155.7 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Invested Capital jumped 307.12% in 2022, then retreated 18.5% in 2024.
• Over 5 years, Invested Capital stood at $113.2 million in 2022, then surged by 68.62% to $190.9 million in 2023, then fell by 12.96% to $166.2 million in 2024, then decreased by 11.91% to $146.4 million in 2025, then fell by 11.13% to $130.1 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $130.1 million, $136.6 million, and $146.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.